Saturday, 11st, May, 2024
7.00 am – 8:00 am | Registration and Welcome
8.00 am – 8:30 am | Opening Ceremony
Welcome address by the Congress Chair
Introduction to the Congress theme and objectives
8:30 am – 10:00 am
Plenary Session 1 “Transplant Trek: From NOW to WOW – State of the Art in
HSCT in 2024 “
„Transplant Challange: Diagnosis and Complexity of Post-allotransplant
Microangiopathy” | Sonata Jodele
Expanding Post-transplant Cyclophosphamide to All Allogeneic Transplants | Is
This the New Standard? Chris Kanakry
CAR T-cell Therapy in Multiple Myeloma | Will It Replace Stem Cell Transplant?
Arun Wiita
10:00 am – 11.00 am
New Frontiers: Improving Transplant Outcomes for Patients with ALL
Johns Hopkin’s Perspective | Jon Webster
UCI Perspective | Stefan Ciurea
11.00 am – 11.30 am | Coffee Break and Networking
Saturday, 11st, May, 2024
11:30 am – 12.30 pm
Special Session | “Think Big in the Small World: Predicting the Risk of HSCT”
Prognostic Models in Allogeneic Transplants | Mohamed Sorror
Tailoring Transplant Approaches for Older Adults – Andrew Artz
12.30 pm – 1.00 pm Sponsored Symposium
1.00 PM – 2.00 PM: Lunch Break
2.00 pm – 2.30 pm Sponsored Symposium
2.30 pm -3.30 pm
Keynote Lectures | Setting the tone:
Translational Research in Hematology and Oncology | William Kaelin Jr. | Nobel
Prize Laureate 2019, Harvard Medical School, Boston, USA
Saturday, 11st, May, 2024
3.30 pm – 4.30 pm
Plenary session 2 – “Advancements and Insights in Stem Cell Transplantation”
Novel Therapeutic Approaches in Stem Cell Transplantation for T Cell Lymphomas
| Shigeo Fuji
AlloHCT Strategies for Inborn Errors of Immunity | Jen Kanakry
Advancing Strategies in Multiple Myeloma Management | Role of Transplantation |
Evangelos Terpos, MD, PhD
4.30 pm – 5.00 pm Afternoon Break and Poster Session
5.00 pm – 7.00 pm
SRTM Session | Oral Presentations
7.30 pm | Dinner
Sunday, 12nd, May, 2024
9.00 am – 10.00 am
Round Table on Myelodysplastic Syndrome (MDS) | Gabriel Ghiaur | Stefan
Ciurea | Alina Tanase
Expert Panel Discussion: Current Therapeutic Strategies for MDS – Role of
Stem Cell Transplantation: Which Patients, When and How?
Interactive Case Discussions: Managing Complex MDS Cases
10.00 am – 12.00 am
Sponsored symposium
12.00 pm – 1.00 pm
Closing Session for both Congresses
Roundup of Key Learnings from the Congress
Future Directions and Opportunities in Hematopoietic Stem Cell Research and
Treatment
Closing Remarks by the Congress Chair
1:00 pm – 2.30 pm
Networking